Type 2 diabetes trials in Latvia

1 of 3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• No phaseEnrolling by invitation
  Post-Market Clinical Follow-Up of the CT3 Series Continuous Glucose Monitoring System: A 14-Day Observational Study Assessing Accuracy, Safety, and Glucose Control in Patients With Type 1 and Type 2 Diabetes Mellitus

  Where

  Riga

  Age

  18 years to 80 years

  People

  72

  Run by

  MDCECRO LLC

  See details and how to joinNCT07122180